Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sampson-Johannes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
Macrophage growth and stimulating factor, M-CSFP Ralph, A Sampson-Johannes
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1988
Enhancement of human monocyte tumoricidal activity by recombinant M-CSFA Sampson-Johannes, J A Carlino
International Journal of Cancer|March 15, 1996
Colonization of human lung grafts in SCID-hu mice by human colon carcinoma cellsA Sampson-Johannes, W Wang, E Shtivelman
Annals of the New York Academy of Sciences|January 1, 1991
Negative regulation of cytokines. Inhibition of the production of interleukin-1 and tumor necrosis factorP Ralph, I Nakoinz, A Sampson-Johannes
Gene Therapy|January 11, 2000
Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 statusC Heise, I Ganly, Y T Kim, et al.
Biochemical and Biophysical Research Communications|November 30, 1988
CSF-1 and C-FMS gene expression in human carcinoma cell linesJ Horiguchi, M L Sherman, A Sampson-Johannes, et al.
Transfusion Medicine (Oxford, England)|August 17, 2005
Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentratesD Pinna, A Sampson-Johannes, M Clementi, et al.
Nature Medicine|June 1, 1997
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsC Heise, A Sampson-Johannes, A Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1992
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factorP Ralph, I Nakoinz, A Sampson-Johannes, et al.
Nature Medicine|October 4, 2000
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyC Heise, T Hermiston, L Johnson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Progress in Clinical and Biological Research|January 1, 1990
Macrophage growth and stimulating factor, M-CSFP Ralph, A Sampson-Johannes
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1988
Enhancement of human monocyte tumoricidal activity by recombinant M-CSFA Sampson-Johannes, J A Carlino
International Journal of Cancer|March 15, 1996
Colonization of human lung grafts in SCID-hu mice by human colon carcinoma cellsA Sampson-Johannes, W Wang, E Shtivelman
Annals of the New York Academy of Sciences|January 1, 1991
Negative regulation of cytokines. Inhibition of the production of interleukin-1 and tumor necrosis factorP Ralph, I Nakoinz, A Sampson-Johannes
Gene Therapy|January 11, 2000
Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 statusC Heise, I Ganly, Y T Kim, et al.
Biochemical and Biophysical Research Communications|November 30, 1988
CSF-1 and C-FMS gene expression in human carcinoma cell linesJ Horiguchi, M L Sherman, A Sampson-Johannes, et al.
Transfusion Medicine (Oxford, England)|August 17, 2005
Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentratesD Pinna, A Sampson-Johannes, M Clementi, et al.
Nature Medicine|June 1, 1997
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsC Heise, A Sampson-Johannes, A Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1992
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factorP Ralph, I Nakoinz, A Sampson-Johannes, et al.
Nature Medicine|October 4, 2000
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyC Heise, T Hermiston, L Johnson, et al.
Pageof 2